US Stem Cell Inc (USRM)
OTHER OTC:USRM
Holding USRM?
Track your performance easily

US Stem Cell (USRM) Financial Statements

26 Followers

US Stem Cell Financial Overview

US Stem Cell's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; US Stem Cell is scheduled to report earnings on August 7, 2019, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ 8.05K$ 10.66K$ 24.52K$ 23.31K$ 23.59K
Gross Profit$ 15.05K$ 8.98K$ 18.27K$ 15.97K$ 14.96K
EBIT$ -374.92K$ -396.62K$ -394.57K$ -1.00M$ -125.08K
EBITDA$ -182.49K$ -227.84K$ -394.57K$ -1.00M$ -125.08K
Net Income Common Stockholders$ -566.62K$ -565.37K$ -570.10K$ -1.16M$ -641.02K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 5.13K$ 30.16K$ 10.33K$ 14.47K$ 39.39K
Total Assets$ 68.04K$ 171.89K$ 71.10K$ 142.36K$ 51.00K
Total Debt$ 8.95M$ 8.75M$ 8.56M$ 8.41M$ 8.02M
Net Debt$ 8.94M$ 8.72M$ 8.55M$ 8.39M$ 7.98M
Total Liabilities$ 14.81M$ 14.37M$ 13.93M$ 13.51M$ 12.82M
Stockholders Equity$ -14.75M$ -14.20M$ -13.86M$ -13.37M$ -12.77M
Cash Flow-
Free Cash Flow$ -43.06K$ -64.67K$ -133.31K$ -63.81K$ -216.70K
Operating Cash Flow$ -43.06K$ -64.67K$ -133.31K$ -63.81K$ -216.70K
Investing Cash Flow-----
Financing Cash Flow$ 18.04K$ 84.50K$ 129.17K$ 38.88K$ 225.76K
Currency in USD

US Stem Cell Earnings and Revenue History

US Stem Cell Debt to Assets

US Stem Cell Cash Flow

US Stem Cell Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis